Russell Investments Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-266
| Closed | -$15.6K | – | 3403 |
|
|
2023
Q4 | $15.6K | Sell |
266
-5,329
| -95% | -$313K | ﹤0.01% | 2775 |
|
|
2023
Q3 | $244K | Sell |
5,595
-53,002
| -90% | -$2.31M | ﹤0.01% | 2449 |
|
|
2023
Q2 | $2.12M | Sell |
58,597
-5,677
| -9% | -$205K | ﹤0.01% | 1527 |
|
|
2023
Q1 | $2.39M | Buy |
64,274
+4,248
| +7% | +$158K | ﹤0.01% | 1470 |
|
|
2022
Q4 | $2.72M | Buy |
60,026
+33,186
| +124% | +$1.5M | 0.01% | 1402 |
|
|
2022
Q3 | $1.87M | Buy |
26,840
+2,701
| +11% | +$188K | ﹤0.01% | 1585 |
|
|
2022
Q2 | $1.62M | Sell |
24,139
-34,115
| -59% | -$2.29M | ﹤0.01% | 1706 |
|
|
2022
Q1 | $4.79M | Buy |
58,254
+9,848
| +20% | +$810K | 0.01% | 1182 |
|
|
2021
Q4 | $7.1M | Buy |
48,406
+9,680
| +25% | +$1.42M | 0.01% | 1069 |
|
|
2021
Q3 | $6.85M | Buy |
38,726
+5,190
| +15% | +$918K | 0.01% | 1078 |
|
|
2021
Q2 | $5.42M | Buy |
33,536
+20,589
| +159% | +$3.33M | 0.01% | 1293 |
|
|
2021
Q1 | $2.22M | Sell |
12,947
-27,913
| -68% | -$4.78M | ﹤0.01% | 1823 |
|
|
2020
Q4 | $8.97M | Buy |
40,860
+5,746
| +16% | +$1.26M | 0.02% | 921 |
|
|
2020
Q3 | $5.83M | Buy |
35,114
+14,338
| +69% | +$2.38M | 0.01% | 1050 |
|
|
2020
Q2 | $2.37M | Sell |
20,776
-3,982
| -16% | -$454K | 0.01% | 1531 |
|
|
2020
Q1 | $1.91M | Sell |
24,758
-4,524
| -15% | -$348K | ﹤0.01% | 1492 |
|
|
2019
Q4 | $3.77M | Buy |
29,282
+6,937
| +31% | +$893K | 0.01% | 1376 |
|
|
2019
Q3 | $1.75M | Sell |
22,345
-185
| -0.8% | -$14.4K | ﹤0.01% | 1753 |
|
|
2019
Q2 | $2.32M | Buy |
22,530
+36
| +0.2% | +$3.71K | ﹤0.01% | 1596 |
|
|
2019
Q1 | $1.65M | Buy |
+22,494
| New | +$1.65M | ﹤0.01% | 1820 |
|
|
2017
Q2 | – | Sell |
-11,309
| Closed | -$59K | – | 3060 |
|
|
2017
Q1 | $59K | Buy |
+11,309
| New | +$59K | ﹤0.01% | 2879 |
|